-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Iuhh7tX2s8dcUSGtuT0GhfWBHpnkz0kzCB3JyC4rZ7o75s3cgCoW2ejNGfXyjW3s 7UmVk4hBlJ33zG7imkXNIA== 0000930413-08-005729.txt : 20080925 0000930413-08-005729.hdr.sgml : 20080925 20080925211017 ACCESSION NUMBER: 0000930413-08-005729 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080923 FILED AS OF DATE: 20080925 DATE AS OF CHANGE: 20080925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RABBANI SHAHRAM K CENTRAL INDEX KEY: 0000901501 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 081089740 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BOULEVARD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 c55083_ex.xml X0303 4 2008-09-23 0 0000316253 ENZO BIOCHEM INC ENZ 0000901501 RABBANI SHAHRAM K C/O ENZO BIOCHEM, INC. 527 MADISON AVENUE NEW YORK NY 10022 1 1 0 0 Treasurer and Secretary Common Stock, par value $0.01 per share 2008-09-23 4 M 0 60755 5.45 A 1828494 D Common Stock, par value $0.01 per share 2008-09-23 4 F 0 29406 11.26 D 1799088 D Employee Stock Option 5.45 2008-09-23 4 M 0 60755 0 D 2002-10-01 2008-10-01 Common Stock, par value $0.01 per share 60755 0 D The Reporting Person exercised a stock option to purchase 60,755 shares of Common Stock and paid the exercise price thereof by the surrender of 29,406 shares of Common Stock, for a net gain in outstanding shares of Common Stock of 31,349 shares. The stated exercise price of the stock option was $5.45. Includes (i) 398,773 shares of Common Stock issuable upon the exercise of options which are exercisable within 60 days from the date hereof, (ii) 1,354 shares of Common Stock held in the name of the Reporting Person's son, (iii) 1,671 shares of Common Stock that the Reporting Person holds as custodian for certain of his nephews, (iv) 3,500 shares of restricted Common Stock, and (v) 4,881 shares of Common Stock held in the Company's 401(k) plan. /s/ Shahram Rabbani 2008-09-25 -----END PRIVACY-ENHANCED MESSAGE-----